Attention-deficit/hyperactivity disorder (ADHD) in the adult population is frequently
associated with comorbid psychiatric diseases that complicate its recognition, diagnosis and …

Children, adolescents and adults with attention-deficit/hyperactivity disorder (ADHD)
experience functional impairment and poor health-related quality of life (HRQoL) in addition …

Objective: Recent trials have demonstrated efficacy of cognitive behavioral therapy (CBT) in
medicated adults with ADHD. Efficacy of CBT in unmedicated versus medicated adults …

ADHD is prevalent in adulthood and stimulant pharmacotherapy is the primary treatment for
uncomplicated presentations. ADHD is associated with significant functional impairment in …

In a recent randomized, double-blind, placebo-controlled trial, we established a robust
efficacy (Cohen'sd= 2.17) of osmotic release oral system-methylphenidate (OROS …

Background ADHD is neurodevelopmental disorder which persists into adulthood.
Presently, therapeutic approaches are mainly pharmacological and psychological whilst the …

Attention-deficit/hyperactivity disorder (ADHD) is commonly known to occur during
childhood, characterized by excessive inattention and/or hyperactivity and impulsivity as …

Methylphenidate (MPH) is widely prescribed for adults with attention deficit hyperactivity
disorder (ADHD), but data on long-term treatment and maintenance of effect are lacking …

Attention-deficit/hyperactivity disorder (ADHD) is a common neurobehavioural disorder with
onset during childhood. It affects a child's development, both at home and at school, and …

Background and aims The pharmacological treatment of individuals with attention deficit
hyperactivity disorder (ADHD) and severe substance use disorder (SUD) is controversial …